Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon
Clinical trial NCT01542788 · COMPLETED
Trial details
- NCT number
- NCT01542788
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2012-11-01
- Enrollment
- 278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.